Acumen Pharmaceuticals (ABOS) Current Leases (2022 - 2024)
Acumen Pharmaceuticals (ABOS) reported Current Leases of $129000.0 for Q3 2024, up 6350.0% on a YoY basis from $2000.0 in Q4 2023, and up 3.2% sequentially from $125000.0 in Q2 2024.
Acumen Pharmaceuticals (ABOS) Current Leases (2022 - 2024) Analysis & Trends
Acumen Pharmaceuticals (ABOS) has 3 years of Current Leases data on file, last reported at $129000.0 in Q3 2024.
- For the quarter ending Q3 2024, Current Leases rose 6350.0% year-over-year to $129000.0; the trailing twelve-month figure through Sep 2024 stood at $129000.0 (up 6350.0% YoY), and the FY2023 full-year result was $756000.0, up 620.0% from the prior year.
- Current Leases rose to $129000.0 in Q3 2024, from $125000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $756000.0 in Q4 2023 to a low of $2000.0 in Q3 2023.
- A 3-year average of $162700.0 and a median of $127000.0 in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases slumped 98.5% in 2023 and soared 6350.0% in 2024, its largest moves.
- Tracing ABOS's Current Leases over 3 years: stood at $105000.0 in 2022, then soared by 620.0% to $756000.0 in 2023, then sank by 82.94% to $129000.0 in 2024.
- Business Quant data shows ABOS's Current Leases at $129000.0 in Q3 2024, $125000.0 in Q2 2024, and $756000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | Acumen Pharmaceuticals | 140.98 Mn | 140.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Dec 31, 2023 | 756,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 133,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 139,000.00 |